Clinical Trial Update: Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on efficacy and safety of NFL-101 for reducing reinforcing properties of cigarettes in smoking cessation and nicotine dependence…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking Cessation

Drugs mentioned

• NFL-101

Snippet

Sponsor: NFL Biosciences SAS | Conditions: Smoking Cessation, Nicotine Dependence | Phase 2 | Status: COMPLETED